Strengthening the metabolic alliance: exercise as an essential partner of obesity pharmacotherapy

Competing interests

J.B. has received speaking fees from Novo Nordisk and Eli Lilly for educational activities related to exercise in people with obesity. A.C. has received speaking fees from Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Sanofi and Menarini and research grants from Eli Lilly, Novo Nordisk and Menarini, and is a member of the DMC of Boehringer Ingelheim. J.R.R. declares no competing interests.